NRX Pharmaceuticals
NRXP
NRXP
24 hedge funds and large institutions have $13M invested in NRX Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 3 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
4% less funds holding
Funds holding: 25 → 24 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
Holders
24
Holding in Top 10
–
Calls
$582K
Puts
$2K
Top Buyers
| 1 | +$1.39M | |
| 2 | +$514K | |
| 3 | +$423K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$273K |
| 5 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$259K |
Top Sellers
| 1 | -$301K | |
| 2 | -$138K | |
| 3 | -$10.1K | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
-$8.38K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
-$2.94K |
